Literature DB >> 25028261

Evaluation of gatifloxacin for its potential to induce antioxidant imbalance and retinopathy in rabbits.

G B Kumbhar1, A M Khan2, S Rampal1.   

Abstract

Gatifloxacin, a fluoroquinolone antibiotic, has been reported to produce several adverse reactions. In the present investigation, gatifloxacin administered at the dose rate of 10 and 20 mg kg(-1) body weight per day, respectively, for 21 consecutive days, was evaluated for its potential to induce antioxidant status alterations and retinal damage in rabbits. A significant alteration in the antioxidant status of rabbits particularly in the high-dose group was observed which is indicated by decreased activity of superoxide dismutase and levels of blood glutathione with a concomitant increase in the activity of catalase, glutathione peroxidase, and glutathione S-transferase enzymes. The activity of glutathione reductase differed nonsignificantly between groups throughout the study period. The levels of malondialdehyde were elevated in the high-dose group. The histopathological examination of eyeball tunics revealed clumping of nuclei of the retinal outer nuclear layer in the gatifloxacin-treated groups. The results from this study indicate that repeated gatifloxacin administration produces a dose-dependent oxidative stress and retinopathy.
© The Author(s) 2014.

Entities:  

Keywords:  Gatifloxacin; antioxidant status; rabbits; retinopathy

Mesh:

Substances:

Year:  2014        PMID: 25028261     DOI: 10.1177/0960327114530743

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

1.  Fluoroquinolone Use and the Risk of Collagen-Associated Adverse Events: A Systematic Review and Meta-Analysis.

Authors:  Xinyu Yu; Ding-Sheng Jiang; Jing Wang; Rui Wang; Taiqiang Chen; Kan Wang; Shiyi Cao; Xiang Wei
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

Review 2.  Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.

Authors:  Krzysztof Michalak; Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Justyna Sobolewska; Piotr Woźniak; Bogusław Sobolewski
Journal:  Oxid Med Cell Longev       Date:  2017-09-25       Impact factor: 6.543

3.  A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.

Authors:  Deanna N Cannizzaro; Lydia F Naughton; Maya Z Freeman; Linda Martin; Charles L Bennett; Cecilia Bove
Journal:  Medicina (Kaunas)       Date:  2021-12-16       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.